Rigel Pharmaceuticals | Costo Del Venduto





Costo Del Venduto Cambiamento Data
Agenus USD 137K 19K 2025-03
Amgen USD 1.79B 128M 2025-12
Anika Therapeutics USD 11.49M 35.48M 2025-03
AstraZeneca USD 3.27B 471M 2025-12
BioMarin Pharmaceutical USD 144.93M 10M 2025-09
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Celldex Therapeutics USD 54.2M 8.94M 2025-06
Daiichi Sankyo JPY 118.28B 37.7B 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Halozyme Therapeutics USD 73M 8.88M 2025-09
Heron Therapeutics USD 9.46M 1.61M 2024-09
Intrexon USD 1.01M 344K 2024-06
Ionis Pharmaceuticals USD 2.34M 1.81M 2025-09
Karyopharm Therapeutics USD 37.43M 2.41M 2024-09
Ligand Pharmaceuticals USD 11.9M 733K 2025-09
MacroGenics USD 44.3M 5.4M 2025-09
Neurocrine Biosciences USD 264M 252.7M 2025-09
Pfizer USD 6.29B 2.12B 2025-12
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Rigel Pharmaceuticals USD 8.03M 5.22M 2024-09
Sangamo BioSciences 2.42M 1.11M 2024-06
Ultragenyx Pharmaceutical USD 27.99M 4.99M 2025-09
Veracyte USD 41.21M 196K 2025-09


Rigel Pharmaceuticals Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.